⌘K
Loading ticker…
As of 2026-08-24, Alkermes Inc. plc (ALKS) has a 3-month relative strength percentile of 89 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 66. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 3.7%, relative volume 0.79×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
ALKS is held by 30 ETFs as of May 2026. Top owner: AVUV at 0.51% weight, $138M notional. Top 3 carry $194M.
Held by 62 ETFs · $910M across latest filings · largest weight 4.48% (SBIO).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| AVUVAvantis U.S. Small Cap Value ETF | 0.51% | $138M | −0.07 pp |
| VTWO | 0.20% | $35M | +0.04 pp |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.35% | $21M | +0.08 pp |
| VHTVanguard Health Care ETF | 0.10% | $20M | +0.03 pp |
| VIOG |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.82% |
| $8M |
| +0.20 pp |
| SBIO | 4.48% | $7M | +1.27 pp |
| QGRO | 0.22% | $5M | −0.04 pp |
| PSCH | 3.71% | $5M | +0.75 pp |
| VTWG | 0.29% | $5M | +0.05 pp |
| XSHQ | 1.84% | $4M | +0.62 pp |
Showing 10 of 30 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ALKS Jan avg: 9.47% median: 9.62% win: 75% σ: 9.64% n: 4 2022-04-12 → 2026-07-31 | ALKS Feb avg: 0.21% median: 1.12% win: 50% σ: 10.69% n: 4 2022-04-12 → 2026-07-31 | ALKS Mar avg: 2.56% median: 0.80% win: 50% σ: 11.56% n: 4 2022-04-12 → 2026-07-31 | ALKS Apr avg: -5.01% median: -4.67% win: 40% σ: 6.15% n: 5 2022-04-12 → 2026-07-31 | ALKS May avg: 6.34% median: 3.47% win: 80% σ: 11.27% n: 5 2022-04-12 → 2026-07-31 | ALKS Jun avg: 5.73% median: 2.99% win: 60% σ: 11.62% n: 5 2022-04-12 → 2026-07-31 | ALKS Jul avg: -4.21% median: -6.50% win: 20% σ: 10.32% n: 5 2022-04-12 → 2026-07-31 | ALKS Aug avg: 1.41% median: 1.91% win: 50% σ: 7.16% n: 4 2022-04-12 → 2026-07-31 (current) | ALKS Sep avg: -1.94% median: -2.83% win: 25% σ: 4.02% n: 4 2022-04-12 → 2026-07-31 | ALKS Oct avg: -4.46% median: -3.26% win: 50% σ: 7.78% n: 4 2022-04-12 → 2026-07-31 | ALKS Nov avg: 4.56% median: 4.48% win: 50% σ: 7.77% n: 4 2022-04-12 → 2026-07-31 | ALKS Dec avg: 3.51% median: 2.28% win: 50% σ: 8.81% n: 4 2022-04-12 → 2026-07-31 |